by Multiplex Detection Immunoassays Market (By Assay Type: Planar Assay, Bead-based Assay; By Technique: Nucleic Acid-based Techniques, Protein-based Techniques, Biosensor-based Techniques; By Application: Disease Testing, Food Contamination Testing, R&D, Veterinary Disease Testing; By End User) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030
The global multiplex detection immunoassays market size is expected to be worth around US$ 3.5 billion by 2030, according to a new report by Vision Research Reports. size was valued at US$ 1.6 billion in 2020 and is anticipated to grow at a CAGR of 7.3% during forecast period 2021 to 2030.
The high prevalence and increase in incidence rate of chronic and infectious diseases are projected to drive the global multiplex detection immunoassays market in the near future.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38200
Growth Factor
Multiplex immunoassays provide sufficient analytical performance to evaluate serum biomarkers that complement each other in the detection of a larger number of patient samples. The use of differentially detectable beads of different regions enables simultaneous identification and quantification of multiple analytes in the same sample allowing the individual immunoassays to be multiplexed.
The market growth is primarily driven by a host of factors, including increasing need for swift and early detection of antibiotic residues for food and environmental protection, significant rise in the prevalence of infectious and chronic diseases, and increase in emphasis on research and development. The outbreak of the COVID-19 pandemic will play a key role in accelerating research and development activities, as researchers and scientists continue to leverage multiplex detection immunoassays for the detection of human coronaviruses worldwide.
Key Players
Leading players operating in the global multiplex detection immunoassays market include Hoffmann-La Roche Ltd., QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories, Thermo Fisher Scientific, Luminex Corporation, and Becton, Dickinson and Company.
Market Segmentation
By Assay Type
- Planar Assay
- Blends Protein Arrays (Multiplexed ELISA)
- Antibody Arrays
- Bead-based Assay
- Magnetic Bead-based
- Non-magnetic Bead-based
By Technique
- Nucleic Acid-based Techniques
- Protein-based Techniques
- Biosensor-based Techniques
By Application
- Disease Testing
- Infectious Disease Testing
- Autoimmune Disease Testing
- Other Diseases Testing
- Food Contamination Testing
- Research & Development
- Veterinary Disease Testing
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Clinical Research Organizations
- Food & Beverages Industry
- Academic & Research Institutes
- Diagnostic Centers
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38200
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Multiplex Detection Immunoassays Market, By Assay Type
7.1. Multiplex Detection Immunoassays Market, by Assay Type, 2021-2030
7.1.1. Planar Assay
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Blends Protein Arrays (Multiplexed ELISA)
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Antibody Arrays
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Bead-based Assay
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Magnetic Bead-based
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Non-magnetic Bead-based
7.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Multiplex Detection Immunoassays Market, By Technique
8.1. Multiplex Detection Immunoassays Market, by Technique, 2021-2030
8.1.1. Nucleic Acid-based Techniques
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Protein-based Techniques
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biosensor-based Techniques
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Multiplex Detection Immunoassays Market, By Application
9.1. Multiplex Detection Immunoassays Market, by Application, 2021-2030
9.1.1. Disease Testing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Infectious Disease Testing
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Autoimmune Disease Testing
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Other Diseases Testing
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Food Contamination Testing
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Research & Development
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Veterinary Disease Testing
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Multiplex Detection Immunoassays Market, By End User
10.1. Multiplex Detection Immunoassays Market, by End User, 2021-2030
10.1.1. Pharmaceutical & Biopharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Clinical Research Organizations
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Food & Beverages Industry
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Academic & Research Institutes
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Diagnostic Centers
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Multiplex Detection Immunoassays Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. Market Revenue and Forecast, by End User (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 12. Company Profiles
12.1. Hoffmann-La Roche Ltd.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. QIAGEN
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck KGaA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Microsynth AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Luminex Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Becton
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Dickinson and Company
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38200
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
